Linda Holtman

Inhibition of mammalian target of rapamycin reduces epileptogenesis and blood–brain barrier leakage but not microglia activation

Erwin A. van Vliet, Grazia Forte, Linda Holtman et al. · Epilepsia · 2012 · 169 citations · Full text

COX-2 inhibition controls P-glycoprotein expression and promotes brain delivery of phenytoin in chronic epileptic rats

Erwin A. van Vliet, Guido Zibell, Anton Pekcec et al. · Neuropharmacology · 2009 · 145 citations · Full text

Neuropeptides, Cox-2 Inhibition, Molecular Neuroscience +13

Effects of SC58236, a selective COX-2 inhibitor, on epileptogenesis and spontaneous seizures in a rat model for temporal lobe epilepsy

Linda Holtman, Erwin A. van Vliet, R. van Schaik et al. · Epilepsy Research · 2009 · 113 citations · Full text

Selective Cox-2 Inhibitor, Neurophysiology, Medicine +9

Cox-2 inhibition can lead to adverse effects in a rat model for temporal lobe epilepsy

Linda Holtman, Erwin A. van Vliet, Peter M. Edelbroek et al. · Epilepsy Research · 2010 · 82 citations · Full text

Neuropsychology, Cox-2 Inhibition, Neurophysiology +9

Blood plasma inflammation markers during epileptogenesis in post–status epilepticus rat model for temporal lobe epilepsy

Linda Holtman, Erwin A. van Vliet, Eleonora Aronica et al. · Epilepsia · 2013 · 46 citations